title: A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas.
abstract: We report that heat shock protein 90 (Hsp90) inhibitors selectively kill diffuse large B cell lymphomas (DLBCLs) that depend on the BCL-6 transcriptional repressor. We found that endogenous Hsp90 interacts with BCL-6 in DLBCL cells and can stabilize BCL-6 mRNA and protein. Hsp90 formed a complex with BCL-6 at its target promoters, and Hsp90 inhibitors derepressed BCL-6 target genes. A stable mutant of BCL-6 rescued DLBCL cells from Hsp90 inhibitor-induced apoptosis. BCL-6 and Hsp90 were almost invariantly coexpressed in the nuclei of primary DLBCL cells, suggesting that their interaction is relevant in this disease. We examined the pharmacokinetics, toxicity and efficacy of PU-H71, a recently developed purine-derived Hsp90 inhibitor. PU-H71 preferentially accumulated in lymphomas compared to normal tissues and selectively suppressed BCL-6-dependent DLBCLs in vivo, inducing reactivation of key BCL-6 target genes and apoptosis. PU-H71 also induced cell death in primary human DLBCL specimens.
authors: Division of Hematology and Oncology, Weill Cornell Medical College of Cornell University, New York, New York, USA.
authors: Leandro C
authors: LC
authors: Cerchietti
authors: Eloisi C
authors: EC
authors: Lopes
authors: Shao Ning
authors: SN
authors: Yang
authors: Katerina
authors: K
authors: Hatzi
authors: Karen L
authors: KL
authors: Bunting
authors: Lucas A
authors: LA
authors: Tsikitas
authors: Alka
authors: A
authors: Mallik
authors: Ana I
authors: AI
authors: Robles
authors: Jennifer
authors: J
authors: Walling
authors: Lyuba
authors: L
authors: Varticovski
authors: Rita
authors: R
authors: Shaknovich
authors: Kapil N
authors: KN
authors: Bhalla
authors: Gabriela
authors: G
authors: Chiosis
authors: Ari
authors: A
authors: Melnick
mesh_terms: D004268:DNA-Binding Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D018841:HSP90 Heat-Shock Proteins / Q000037:antagonists & inhibitors*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000378:metabolism* / Q000473:pathology; D011485:Protein Binding; D051560:Proto-Oncogene Proteins c-bcl-6
chemical_list: C084103:BCL6 protein, human; D004268:DNA-Binding Proteins; D018841:HSP90 Heat-Shock Proteins; D051560:Proto-Oncogene Proteins c-bcl-6